Cited by 54Liver Disease Diagnosis and TreatmentDiet, Metabolism, and DiseaseNutritional Studies and Diet

Effects of two personalized dietary strategies during a 2-year intervention in subjects with nonalcoholic fatty liver disease: a randomized trial

Open access
Marin‐Alejandre, Bertha A., Cantero, Irene, Perez‐Diaz‐del‐Campo, Nuria, Monreal, Jose I., Elorz, Mariana, Herrero, Jose I., Benito‐Boillos, Alberto, Quiroga, Jorge +7 more·2021·Liver International

Abstract

BACKGROUND AND OBJECTIVES: Nonalcoholic fatty liver disease (NAFLD) management is focused on lifestyle modifications, but long-term maintenance is a challenge for many individuals. This study aimed to evaluate the long-term effects of two personalized energy-restricted dietary strategies on weight loss, metabolic and hepatic outcomes in overweight/obese subjects with NAFLD. METHODS: Ninety-eight subjects from the Fatty Liver in Obesity (FLiO) study (NCT03183193) were randomly assigned to the American Heart Association (AHA) or the FLiO dietary group in a 2-year controlled trial. Anthropometry, body composition (DXA), biochemical parameters and hepatic status (ultrasonography, Magnetic Resonance Imaging, and elastography) were assessed at baseline, 6, 12 and 24 months. RESULTS: Both the AHA and FLiO diets significantly reduced body weight at 6 (-9.7% vs -10.1%), 12 (-6.7% vs -9.6%), and 24 months (-4.8% vs -7.6%) with significant improvements in body composition, biochemical and liver determinations throughout the intervention. At the end of the follow-up, the FLiO group showed a greater decrease in ALT, liver stiffness and Fatty Liver Index, among others, compared to AHA group, although these differences were attenuated when the analyses were adjusted by weight loss percentage. The FLiO group also showed a greater increase in adiponectin compared to AHA group. CONCLUSIONS: The AHA and FLiO diets were able to improve body weight and body composition, as well as metabolic and hepatic status of participants with overweight/obesity and NAFLD within a 2-year follow-up. These findings show that both strategies are suitable alternatives for NAFLD management. However, the FLiO strategy may provide more persistent benefits in metabolic and hepatic parameters.

Integrity signals

Registry

Crossref · 10.1111/liv.14818

Cites

50 of 50 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Only a few studies have performed 12-24 month follow-ups, showing a maximal weight loss at 6 months, followed by a gradual weight regain to a net weight loss of about 5% at 12-24 months and partial regain of liver lipid content and stiffness.

    “Only a few studies have performed 1224monthfollow-ups,showingamaximal weightloss at6 months, followed by a gradual weight regain to a net weight loss of about 5% at 12-24 months and partial regain of liver lipid content and stiffness. 286 -288”

Cites

Flagged first, then by citations

1 of the 51 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Marin‐Alejandre, B. A., Cantero, I., Perez‐Diaz‐del‐Campo, N., Monreal, J. I., Elorz, M., Herrero, J. I., Benito‐Boillos, A., Quiroga, J., Martinez‐Echeverria, A., Uriz‐Otano, J. I., Huarte‐Muniesa, M. P., Tur, J. A., Martinez, J. A., Abete, I., & Zulet, M. A.
Affiliations
  • Department of Nutrition Food Sciences and Physiology and Centre for Nutrition Research Faculty of Pharmacy and Nutrition University of Navarra Pamplona Spain
  • Universidad de Navarra (ES)
  • Navarre Institute of Health Research (ES)
  • Navarra Institute for Health Research (IdiSNA) Pamplona Spain
  • Complejo Hospitalario de Navarra (ES)
  • Instituto de Salud Carlos III (ES)
Venue
Liver International
Publisher
Wiley
Published
2021-03
Volume
41
Issue
7
Pages
1532-1544
ISSN
  • 0106-9543 (ISSN-L)
  • 1478-3223
  • 1478-3231
OpenAlex
W3127576437
Cited by
54
References
51
Citations by year
2026: 10 · 2025: 12 · 2024: 9 · 2023: 15 · 2022: 5 · 2021: 3
FWCI
5.76
Type
journal article
Language
en
Open access
Locations
  • Liver International (publishedVersion)
  • PubMed (publishedVersion)
  • Deposito Adademico Digital Universidad De Navarra (University of Navarra) (submittedVersion, other-oa)
Funders
  • Consejo Nacional de Ciencia y Tecnología (440104/2016)
  • Centro de Investigación Biomédica en Red-Fisiopatología de la Obesidad y Nutrición (CB12/03/3002)
  • Fundació la Marató de TV3 (201630.10)
Topics
  • Health Sciences › Medicine › Epidemiology › Liver Disease Diagnosis and Treatment
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diet, Metabolism, and Disease
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Nutritional Studies and Diet
Keywords
non-alcoholic fatty liver disease, personalized diet, hypocaloric diet, weight loss, obesity, body composition, liver stiffness, fatty liver index, adiponectin, long-term dietary intervention, metabolic outcomes
MeSH terms
Body Weight, Diet, Humans, Liver, Obesity, Weight Loss, Non-alcoholic Fatty Liver Disease

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review